Shots:
- RION has launched RION Vet, a veterinary biotechnology subsidiary, with exclusive global rights to RION’s exosome-based therapeutic platform for animal health
- RION Vet is developing ePEP-01, a cell-free, shelf-stable platelet-derived biologic, for equine musculoskeletal disorders, which was evaluated in over 50 horses for >4yrs., showing improvement in lameness, with favorable safety
- RION Vet leverages RION’s biomanufacturing platform to expand into canine musculoskeletal, dermatologic, wound healing, ocular, respiratory, & cardiac conditions. The company has also completed a $15M Series A financing
Ref: BusinessWire| Image: RION | Press Release
Related News:- Phibro Animal Health Unveils Restoris Piezoelectric Dental Gel for Dogs in the US
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
